Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feld

Showing results (411-420 of 451) with videos related to

Pageof 46
Sort By:
AIDS (London, England)|July 19, 2023
Reinfection incidence and risk among people treated for recent hepatitis C virus infectionMarianne Martinello, Joanne M Carson, Marc Van Der Valk, et al.
Surgery|May 7, 2025
Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international studyWoo Jin Choi, Tommy Ivanics, Marco Claasen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2017
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label StudyJordan J Feld, Alnoor Ramji, Stephen D Shafran, et al.
Surgery|May 29, 2026
Corrigendum to "Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international study" [Surgery 183 (2025) 109396]Woo Jin Choi, Tommy Ivanics, Marco Claasen, et al.
Canadian Liver Journal|August 22, 2022
Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH)Giada Sebastiani, Keyur Patel, Vlad Ratziu, et al.
Journal of Clinical Epidemiology|March 24, 2024
Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, CanadaZoë R Greenwald, Dan Werb, Jordan J Feld, et al.
Hepatology Communications|February 7, 2018
Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic reviewSofia R Bartlett, Jason Grebely, Auda A Eltahla, et al.
JHEP Reports : Innovation in Hepatology|October 27, 2025
Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosisLesley A Patmore, Lilian Y Liang, George Papatheodoridis, et al.
Canadian Liver Journal|August 22, 2022
Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplantVictor Dong, Maxime Gosselin, Nishita Jagarlamudi, et al.
Cancer|January 9, 2020
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMsAaron R Hansen, Kari Ala-Leppilampi, Chris McKillop, et al.
Pageof 46

Showing results (411-420 of 451) with videos related to

Sort By:
Pageof 46
AIDS (London, England)|July 19, 2023
Reinfection incidence and risk among people treated for recent hepatitis C virus infectionMarianne Martinello, Joanne M Carson, Marc Van Der Valk, et al.
Surgery|May 7, 2025
Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international studyWoo Jin Choi, Tommy Ivanics, Marco Claasen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2017
Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label StudyJordan J Feld, Alnoor Ramji, Stephen D Shafran, et al.
Surgery|May 29, 2026
Corrigendum to "Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international study" [Surgery 183 (2025) 109396]Woo Jin Choi, Tommy Ivanics, Marco Claasen, et al.
Canadian Liver Journal|August 22, 2022
Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH)Giada Sebastiani, Keyur Patel, Vlad Ratziu, et al.
Journal of Clinical Epidemiology|March 24, 2024
Validation of case-ascertainment algorithms using health administrative data to identify people who inject drugs in Ontario, CanadaZoë R Greenwald, Dan Werb, Jordan J Feld, et al.
Hepatology Communications|February 7, 2018
Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic reviewSofia R Bartlett, Jason Grebely, Auda A Eltahla, et al.
JHEP Reports : Innovation in Hepatology|October 27, 2025
Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosisLesley A Patmore, Lilian Y Liang, George Papatheodoridis, et al.
Canadian Liver Journal|August 22, 2022
Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplantVictor Dong, Maxime Gosselin, Nishita Jagarlamudi, et al.
Cancer|January 9, 2020
Development of the Functional Assessment of Cancer Therapy-Immune Checkpoint Modulator (FACT-ICM): A toxicity subscale to measure quality of life in patients with cancer who are treated with ICMsAaron R Hansen, Kari Ala-Leppilampi, Chris McKillop, et al.
Pageof 46